BIVDA Press Releases

22Oct

BIVDA comment on the Health and Social Care Committee’s report into Antimicrobial resistance

22nd October 2018

Today the Health and Social Care Committee has published its report on Antimicrobial resistance.

The report calls for visible and active Government leadership to tackle Antimicrobial resistance (AMR) and for AMR to be firmly established as a top five policy priority for the Government.

Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Urgent action is required to halt AMR. While the widespread use of broad-spectrum antibiotics has helped to create multi-drug resistant strains of bacteria, greater adoption of IVDs would lead to a reduction in cases of unnecessary antibiotic prescribing by reducing time to appropriate treatment decision and allowing for a more targeted use of therapy against infection.” 

“We therefore welcome the Committee’s conclusion that encouraging the development of rapid diagnostic testing should be considered alongside the action to promote the development of new antimicrobials. We look forward to continuing to contribute a clear voice on the importance of in vitro diagnostics in tackling AMR and to working together with government and policymakers to build on the urgent issues raised in today’s report”. 

The report by the Health and Social Care Committee into Antimicrobial resistance can be found here.

For more information on the In Vitro Diagnostics (IVD) industry Antimicrobial Resistance (AMR) Declaration, click here

 

Related

BIVDA Response to 2017 Budget

The Chancellor of the Exchequer has today (22 November) delivered the Government’s 2017 Budget.

Read More >

New report highlights the value of near patient testing

BIVDA launches new report on the value of near patient testing

Read More >

BIVDA comment on Withdrawal Agreement and political declaration

Doris-Ann Williams, Chief Executive of BIVDA, comments on the announcement of the Withdrawal Agreeme...

Read More >

BIVDA Board elects Darren Stenlake as Chair

Darren Stenlake (Sysmex UK Ltd) has been elected as Chairman of the BIVDA Board

Read More >

BIVDA Launches IVD Value Story

The British In Vitro Diagnostics Association (BIVDA) has today (25 October) launched its new report ...

Read More >

BIVDA and Diabetes UK call for urgent action on blood glucose monitoring

BIVDA and Diabetes UK are calling for healthcare professionals (HCPs) to take urgent action and chec...

Read More >